Related Experiment Video

Updated: Aug 16, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Multiorgan sensitivity to anticarcinogenesis by the organoselenium 1,4-phenylenebis(methylene)selenocyanate

K el-Bayoumy1, C V Rao, B S Reddy

  • 1American Health Foundation, Valhalla, NY 10595, USA. kelbayoumy@aol.com

Nutrition and Cancer
|January 22, 2002
PubMed

Insights

The chemical structure of selenium compounds is key for effective cancer prevention. 1,4-phenylenebis(methylene)selenocyanate shows strong chemopreventive effects against various cancers and may prevent metastasis.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Cancer Chemoprevention

Background:

  • The form of selenium significantly impacts its efficacy in cancer chemoprevention.
  • Synthetic organoselenium compounds offer potential for tailored therapeutic effects with reduced toxicity.

Purpose of the Study:

  • To evaluate the chemopreventive potential of synthetic organoselenium compounds.
  • To investigate the role of structural modifications in enhancing chemopreventive efficacy and minimizing side effects.

Main Methods:

  • Administration of 1,4-phenylenebis(methylene)selenocyanate in experimental models of carcinogenesis.
  • Metabolism studies of organoselenium compounds.

Main Results:

  • 1,4-phenylenebis(methylene)selenocyanate demonstrated potent chemopreventive activity against colon, mammary, lung, and oral cancer development.
  • Aromatic selenol intermediates are hypothesized to be crucial for cancer chemoprevention.

Conclusions:

  • The structure of selenium compounds is critical for successful clinical application.
  • 1,4-phenylenebis(methylene)selenocyanate is a promising chemopreventive agent with potential applications in preventing metastatic disease.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...